Lundi, 28 Mai 2018
Dernières nouvelles
Principale » Janus Capital Management LLC Sells 2201352 Shares of Freeport-McMoran, Inc. (FCX)

Janus Capital Management LLC Sells 2201352 Shares of Freeport-McMoran, Inc. (FCX)

18 Juillet 2017

Hanlon Investment Management Inc. acquired a new stake in shares of Freeport-McMoran during the fourth quarter worth approximately $2,282,000. The Partner Fund Management Lp holds 2.72 million shares with $92.23 million value, up from 1.75 million last quarter. The institutional investor owned 62,294 shares of the natural resource company's stock after buying an additional 44,344 shares during the period. It has by 0.00% the S&P500. It dived, as 61 investors sold Freeport-McMoRan Inc shares while 223 reduced holdings.

FCX has been the topic of a number of recent analyst reports. Acrospire Investment Management LLC purchased a new position in shares of Freeport-McMoran during the first quarter worth $122,000. (NYSE:BRK.B) declined -0.13% to $169.47.

Chevy Chase Trust Holdings, Inc. bolstered its position by buying 633,321 shares an increase of 129.8% from 03/31/2017 to 06/30/2017. The stock increased 0.96% or $0.12 during the last trading session, reaching $12.6. Freeport-McMoran, Inc. has a 12 month low of $9.24 and a 12 month high of $17.06. It has underperformed by 9.87% the S&P500.

Since February 1, 2017, it had 0 insider purchases, and 4 selling transactions for $2.34 million activity.

Zillow Group, Inc. has a consensus outperform rating from 17 Wall Street analysts, and the number of shares now sold short amount to at least 16.68% of shares outstanding. Freeport-McMoRan Inc (NYSE:FCX) has risen 6.83% since July 17, 2016 and is uptrending. Mirador Cap Prtn Lp has invested 0.16% in Freeport-McMoRan Inc (NYSE:FCX). Therefore 25% are positive. Freeport-McMoran Copper & Gold had 64 analyst reports since July 28, 2015 according to SRatingsIntel. Vetr lowered shares of Freeport-McMoran from a "strong-buy" rating to a "buy" rating and set a $14.64 target price for the a research note on Monday, April 10th. FBR & Co restated a "market perform" rating and set a $13.00 price objective on shares of Freeport-McMoran in a research report on Tuesday, March 28th. Cantor Fitzgerald maintained it with "Buy" rating and GBX 24 target in Wednesday, September 21 report. On Saturday, August 15 the stock rating was maintained by Macquarie Research with "Outperform". As per Friday, November 4, the company rating was maintained by Imperial Capital. On Tuesday, March 21 the stock rating was upgraded by Deutsche Bank to "Hold". As per Tuesday, August 18, the company rating was maintained by Morgan Stanley. The company was maintained on Tuesday, June 27 by BMO Capital Markets.

Collins: Eight to 10 Republican senators have serious concerns about health bill
Rand Paul (R-KY) thinks the BCRA is too Obamacare familiar , retaining numerous latter bill's taxes and regulations. And that's the whole point of the Obamacare repeal movement - lower the cost of insurance for working families.

Investors sentiment increased to 1.03 in 2016 Q4. Its down 0.02, from 0.98 in 2016Q3. 99 funds opened positions while 175 raised stakes. 118.40 million shares or 1.23% less from 119.88 million shares in 2016Q3 were reported. Foundation holds 501,539 shares or 1.12% of its portfolio. Victory Capital Mgmt Incorporated holds 3.23 million shares. Equities research analysts expect that Freeport-McMoran, Inc. will post $0.99 EPS for the current year. Keybank National Association Oh stated it has 10,848 shares or 0% of all its holdings. Next Fincl Gp holds 0% of its portfolio in Freeport-McMoRan Inc (NYSE:FCX) for 19,800 shares. Guardian Investment Mngmt reported 38,866 shares stake. Wesbanco State Bank has 11,207 shares for 0.01% of their portfolio. Asset Management invested in 0.05% or 17,571 shares. Kornitzer Capital Mgmt Incorporated Ks owns 140,000 shares or 0.07% of their U.S. portfolio.

Shares of Freeport-McMoran, Inc.

Shikiar Asset Management Inc decreased Whitewave Foods Company (NYSE:WWAV) stake by 35,525 shares to 112,335 valued at $6.25M in 2016Q4. The target implies a 14.84% spike from where the shares are now trading. Five research analysts have rated the stock with a sell rating, nine have assigned a hold rating, three have assigned a buy rating and one has issued a strong buy rating to the company's stock. Therefore 100% are positive. The firm has "Buy" rating by UBS given on Thursday, December 1. Deutsche Bank maintained the stock with "Buy" rating in Monday, August 31 report. The stock of The Medicines Company (NASDAQ:MDCO) earned "Hold" rating by Oppenheimer on Wednesday, July 12. Jefferies maintained The Medicines Company (NASDAQ:MDCO) rating on Monday, June 26.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.